You are here

  • Home
  • Archive
  • Volume 78, Issue Suppl 2
  • FRI0261 RISK FACTORS FOR TREATMENT FAILURE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB PLUS PREDNISONE VERSUS PREDNISONE ALONE

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Friday, 14 June 2019
Vasculitis
FRI0261 RISK FACTORS FOR TREATMENT FAILURE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB PLUS PREDNISONE VERSUS PREDNISONE ALONE
Free

 

Online download statistics by month:

Online download statistics by month: June 2019 to April 2023

AbstractFullPdf
Jun 201934024
Jul 20193408
Aug 20194909
Sep 201941017
Oct 20191905
Nov 20192704
Dec 20191702
Jan 20204709
Feb 20201302
Mar 20202407
Apr 20201302
May 20201306
Jun 20201106
Jul 20202106
Aug 20201105
Sep 20202305
Oct 20203804
Nov 20201703
Dec 20201601
Jan 2021403
Feb 2021703
Mar 2021901
Apr 2021800
May 2021306
Jun 2021203
Jul 2021104
Aug 2021104
Sep 2021103
Oct 202122017
Nov 202143017
Dec 20211607
Jan 20221200
Feb 2022802
Mar 202226015
Apr 2022801
May 202222012
Jun 20221306
Jul 2022601
Aug 2022401
Sep 2022606
Oct 2022401
Nov 2022203
Dec 20221103
Jan 2023805
Feb 20231704
Mar 20231401
Apr 2023402
Total7500256